Saccharomyces cerevisiae‐ and Candida albicans‐Derived Mannan Induced Production of Tumor Necrosis Factor Alpha by Human Monocytes in a CD14‐ and Toll‐Like Receptor 4‐Dependent Manner

The cytokine‐inducing activities of fungal polysaccharides were examined in human monocytes in culture, with special reference to CD14 and Toll‐like receptors (TLRs). Tumor necrosis factor alpha (TNF‐α) production by monocytes was markedly induced in a dose‐dependent manner upon stimulation with cell walls from Candida albicans and mannan from Saccharomyces cerevisiae and C. albicans, although relatively high concentrations (10 to 100 μg/ml) of stimulants were required for activation as compared with the reference lipopolysaccharide (LPS) (1 to 10 ng/ml). The yeast form C. albicans and its mannan and cell wall fractions exhibited higher TNF‐α production than respective preparations from the hyphal form. Only slight TNF‐α production was induced by the S. cerevisiae glucan. The TNF‐α production triggered by reference LPS and purified fungal mannans required the presence of LPS‐binding protein (LBP), and these responses were inhibited by anti‐CD14 and anti‐TLR4 antibodies, but not by anti‐TLR2 antibody. In contrast to the activity of LPS, the activity of purified S. cerevisiae mannan was not inhibited by polymyxin B. These findings suggested that the mannan‐LBP complex is recognized by CD14 on monocytes and that signaling through TLR4 leads to the production of proinflammatory cytokines in a manner similar to that induced by LPS.

[1]  T. Ogawa,et al.  Bacterial Fimbriae and Their Peptides Activate Human Gingival Epithelial Cells through Toll-Like Receptor 2 , 2001, Infection and Immunity.

[2]  S. Akira,et al.  Discrimination of bacterial lipoproteins by Toll-like receptor 6. , 2001, International immunology.

[3]  K. Miyake,et al.  Micrococcus luteus Teichuronic Acids Activate Human and Murine Monocytic Cells in a CD14- and Toll-Like Receptor 4-Dependent Manner , 2001, Infection and Immunity.

[4]  A. Aasen,et al.  Involvement of CD14 and Toll-Like Receptors in Activation of Human Monocytes by Aspergillus fumigatus Hyphae , 2001, Infection and Immunity.

[5]  S. Ghosh,et al.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. , 2001, The Journal of clinical investigation.

[6]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Chiani,et al.  Differential chemokine response of human monocytes to yeast and hyphal forms of Candida albicans and its relation to the β‐1,6 glucan of the fungal cell wall , 2000, Journal of leukocyte biology.

[8]  L. Ryan,et al.  The cytokine stimulating activity of (1-->3)-beta-D-glucans is dependent on the triple helix conformation. , 2000, Carbohydrate research.

[9]  P. Godowski,et al.  Toll-Like Receptor 4, But Not Toll-Like Receptor 2, Is a Signaling Receptor for Escherichia and Salmonella Lipopolysaccharides1 , 2000, The Journal of Immunology.

[10]  F. Mustafa,et al.  Candida albicans and Saccharomyces cerevisiae cell wall mannans produce fever in rats: role of nitric oxide and cytokines. , 2000, Life sciences.

[11]  Y. Adachi,et al.  Measurement of blood clearance time by Limulus G test of Candida-water soluble polysaccharide fraction, CAWS, in mice. , 2000, FEMS immunology and medical microbiology.

[12]  S. Vogel,et al.  Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.

[13]  P. Tobias,et al.  LPS and LAM activation of the U373 astrocytoma cell line: Differential requirement for CD14 , 2000, Journal of endotoxin research.

[14]  Y. Adachi,et al.  Immunopharmacological and immunotoxicological activities of a water-soluble (1-->3)-beta-D-glucan, CSBG from Candida spp. , 2000, International journal of immunopharmacology.

[15]  K. Takeda,et al.  Cutting Edge: Cell Surface Expression and Lipopolysaccharide Signaling Via the Toll-Like Receptor 4-MD-2 Complex on Mouse Peritoneal Macrophages1 , 2000, The Journal of Immunology.

[16]  D. Golenbock,et al.  Human Toll-Like Receptor 2 Mediates Monocyte Activation by Listeria monocytogenes, But Not by Group B Streptococci or Lipopolysaccharide1 , 2000, The Journal of Immunology.

[17]  S. Akira,et al.  Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway1 , 2000, The Journal of Immunology.

[18]  D. Golenbock,et al.  The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. , 1999, Journal of immunology.

[19]  A. Aderem,et al.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.

[20]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[21]  M. Gershwin,et al.  Mushrooms, tumors, and immunity. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[22]  Y. Adachi,et al.  Chemical and immunochemical characterization of limulus factor G-activating substance of Candida spp. , 1999, FEMS immunology and medical microbiology.

[23]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[24]  L. Larivière,et al.  Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. , 1999, Journal of immunology.

[25]  V. Vetvicka,et al.  Therapeutic intervention with complement and β-glucan in cancer , 1999 .

[26]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[27]  Y. Adachi,et al.  Solubilization of yeast cell-wall beta-(1-->3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. , 1999, Carbohydrate research.

[28]  L. Larivière,et al.  Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.

[29]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[30]  M. Rothe,et al.  Human Toll-like Receptor 2 Confers Responsiveness to Bacterial Lipopolysaccharide , 1998, The Journal of experimental medicine.

[31]  A. Gurney,et al.  Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling , 1998, Nature.

[32]  J. Berman,et al.  Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. , 1998, Science.

[33]  G. Fink,et al.  Nonfilamentous C. albicans Mutants Are Avirulent , 1997, Cell.

[34]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[35]  J. Hudson,et al.  Intravenous injection of Candida-derived mannan results in elevated tumor necrosis factor alpha levels in serum , 1996, Infection and immunity.

[36]  T. Kirkland,et al.  CD14 Is a Cell-activating Receptor for Bacterial Peptidoglycan* , 1996, The Journal of Biological Chemistry.

[37]  K. Murphy,et al.  Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway , 1996, Infection and immunity.

[38]  D. Wachsmann,et al.  Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-alpha release. , 1995, Journal of immunology.

[39]  H. Flad,et al.  Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures , 1994, Infection and immunity.

[40]  A. Tomasz,et al.  CD14 is a pattern recognition receptor. , 1994, Immunity.

[41]  R. Sawyer,et al.  Secretion of TNF‐α by alveolar macrophages in response to Candida albicans mannan , 1994, Journal of leukocyte biology.

[42]  M. Otterlei,et al.  Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction , 1993, Infection and immunity.

[43]  T. Lee,et al.  Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. , 1993, The Journal of clinical investigation.

[44]  M. Puliti,et al.  Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans , 1992, Infection and immunity.

[45]  R. Nelson,et al.  Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action , 1991, Clinical Microbiology Reviews.

[46]  R. Ulevitch,et al.  Structure and function of lipopolysaccharide binding protein. , 1990, Science.

[47]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[48]  S. Goyert,et al.  The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. , 1988, Journal of immunology.

[49]  R. Ulevitch,et al.  Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum , 1986, The Journal of experimental medicine.

[50]  H. Tamura,et al.  A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[51]  T. Mikami,et al.  Lethal Effect of Neutral Mannan Fraction of Bakers' Yeast in Mice , 1984, Microbiology and immunology.

[52]  T. Mikami,et al.  Pyrogenicity of Yeast Mannans in Rabbits , 1984, Microbiology and immunology.

[53]  W. Bessler,et al.  Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. , 1983, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[54]  W. Bessler,et al.  B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein. , 1982, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[55]  T. Mikami,et al.  Action of alkaline sodium borohydride on fractions of d-mannans from bakers' yeast (Saccharomyces cerevisiae) , 1982 .

[56]  M. Suzuki,et al.  Growth-inhibitory activity of the D-mannan of Saccharomyces cerevisiae X2180-1A-5 mutant strain against mouse-implanted sarcoma 180 and Ehrlich-carcinoma solid tumor. , 1980, Carbohydrate research.

[57]  T. Mikami,et al.  Preparation of yeast mannan derivatives by stearoylation and phosphorylation. , 1976, Chemical & pharmaceutical bulletin.

[58]  A. Wardlaw,et al.  THE PROPERDIN SYSTEM AND IMMUNITY , 1956, The Journal of experimental medicine.

[59]  Louis Pillemer,et al.  THE PROPERDIN SYSTEM AND IMMUNITY III. THE ZYMOSAN ASSAY OF PROPERDIN , 1956 .